# FDA recall D-0322-2020

> **Sato Pharmaceutical Inc.** · Class III · drug recall initiated 2019-10-01.

## Product

Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 49873-803-01. UPC 4987301603

## Reason for recall

Subpotent Drug

## Distribution

Nationwide within the United States, Guam and Saipan

## Key facts

- **Recall number:** D-0322-2020
- **Recalling firm:** Sato Pharmaceutical Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-10-01
- **Report date:** 2019-11-20
- **Termination date:** 2020-08-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Torrance, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0322-2020

## Citation

> AI Analytics. FDA recall D-0322-2020. Retrieved 2026-06-08 from https://api.ai-analytics.org/recall/D-0322-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*